Aybintio (abaloparatide)
Aybintio is a prescription medicine used to treat osteoporosis in postmenopausal women at high risk…
Abstract Distichiasis is believed to have a genetic basis, with mutations in genes such as FOXC2 and SOX18 potentially playing a role in its pathogenesis. The condition can manifest at any age and affects individuals of all genders and ethnic backgrounds. Further research is warranted to elucidate the precise genetic mechanisms underlying distichiasis and its…… Read More »